These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9632021)

  • 1. Compatibility of calcipotriene with other topical medications.
    Patel B; Siskin S; Krazmien R; Lebwohl M
    J Am Acad Dermatol; 1998 Jun; 38(6 Pt 1):1010-1. PubMed ID: 9632021
    [No Abstract]   [Full Text] [Related]  

  • 2. Vitamin D and topical therapy.
    Lebwohl M
    Cutis; 2002 Nov; 70(5 Suppl):5-8. PubMed ID: 12467332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis.
    Lebwohl M; Siskin SB; Epinette W; Breneman D; Funicella T; Kalb R; Moore J
    J Am Acad Dermatol; 1996 Aug; 35(2 Pt 1):268-9. PubMed ID: 8708035
    [No Abstract]   [Full Text] [Related]  

  • 4. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcipotriene for psoriasis.
    Med Lett Drugs Ther; 1994 Aug; 36(928):70-1. PubMed ID: 8035754
    [No Abstract]   [Full Text] [Related]  

  • 6. Dovobet ointment under occlusion overnight for troublesome scalp psoriasis.
    Downs AM
    Acta Derm Venereol; 2006; 86(1):57-8. PubMed ID: 16585991
    [No Abstract]   [Full Text] [Related]  

  • 7. Psoriasis in infancy: therapy with calcipotriene ointment.
    Travis LB; Silverberg NB
    Cutis; 2001 Nov; 68(5):341-4. PubMed ID: 11766119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
    McCormack PL
    Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and systemic therapy.
    van de Kerkhof P
    Cutis; 2002 Nov; 70(5 Suppl):16-20. PubMed ID: 12467335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical vitamin D analogs.
    Kieffer MA
    Dermatol Nurs; 2004 Feb; 16(1):89-90, 93, 100. PubMed ID: 15022510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial.
    Menter A; Gold LS; Bukhalo M; Grekin S; Kempers S; Boyce BM; Ganslandt C; Villumsen J; Lebwohl M
    J Drugs Dermatol; 2013 Jan; 12(1):92-8. PubMed ID: 23377334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcipotriol and betamethasone dipropionate (Dovobet, Daivobet): a new formulation for the treatment of psoriasis.
    Poulin Y
    Skin Therapy Lett; 2002 Jun; 7(6):1-3. PubMed ID: 12223976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical calcipotriene ointment and etretinate: another combination therapy for psoriasis vulgaris.
    Vázquez-López F; Pérez-Oliva N; Hernandez-Mejia R
    J Am Acad Dermatol; 1997 May; 36(5 Pt 1):803. PubMed ID: 9146555
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial.
    White S; Vender R; Thaçi D; Haverkamp C; Naeyaert JM; Foster R; Martinez Escribano JA; Cambazard F; Bibby A
    Am J Clin Dermatol; 2006; 7(3):177-84. PubMed ID: 16734505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical calcipotriene has no short-term effect on calcium and bone metabolism of patients with psoriasis.
    Guzzo C; Lazarus G; Goffe BS; Katz HI; Lowe NJ; Pincus SH
    J Am Acad Dermatol; 1996 Mar; 34(3):429-33. PubMed ID: 8609254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study.
    Pariser DM; Pariser RJ; Breneman D; Lebwohl M; Kalb R; Moore J; Moss H; Parker C; Fiedler V
    Arch Dermatol; 1996 Dec; 132(12):1527. PubMed ID: 8961897
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of psoriasis: role of calcipotriene.
    Kirsner RS; Federman D
    Am Fam Physician; 1995 Jul; 52(1):237-40, 243-4. PubMed ID: 7604767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.